technetium has been researched along with Nasopharyngeal Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Gray, B; Li, Y; Liu, C; Luo, J; Pak, KY; Qin, X; Xu, X; Yang, Z; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for technetium and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using
Topics: Animals; Antineoplastic Agents, Immunological; Bacteriocins; Cell Line, Tumor; Cetuximab; Combined Modality Therapy; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Peptides; Technetium; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |